Deal sells 2,969,685 of the company's common shares at $1.01 per share
By Devika Patel
Knoxville, Tenn., Feb. 1 - NeurogesX, Inc. said it completed a $3 million private placement of stock on Jan. 31.
The company sold 2,969,685 common shares at $1.01 per share. The price per share reflects a 0.98% discount to the $1.02 closing share price on Jan. 30.
Based in San Carlos, Calif., NeurogesX is a specialty biopharmaceutical company focused on neuropathic pain.
| Issuer: | NeurogesX, Inc.
|
| Issue: | Common stock
|
| Amount: | $3 million
|
| Shares: | 2,969,685
|
| Price: | $1.01
|
| Warrants: | No
|
| Settlement date: | Jan. 31
|
| Stock symbol: | Nasdaq: NGSX
|
| Stock price: | $1.02 at close Jan. 30
|
| Market capitalization: | $29.99 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
